Daré Bioscience Statistics

Total Valuation

Daré Bioscience has a market cap or net worth of $25.49 million. The enterprise value is $18.73 million.

Market Cap	25.49M
Enterprise Value	18.73M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Daré Bioscience has 8.85 million shares outstanding. The number of shares has increased by 13.25% in one year.

Current Share Class	8.85M
Shares Outstanding	8.85M
Shares Change (YoY)	+13.25%
Shares Change (QoQ)	+9.23%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	9.31%
Float	8.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	983.79
Forward PS	2.69
PB Ratio	-2.67
P/TBV Ratio	n/a
P/FCF Ratio	4.24
P/OCF Ratio	3.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	722.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	3.11

Financial Position

The company has a current ratio of 0.56

Current Ratio	0.56
Quick Ratio	0.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	0.59
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-86.98%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	856.71%
Revenue Per Employee	$1,126
Profits Per Employee	-$72,893
Employee Count	23
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.81% in the last 52 weeks. The beta is 1.20, so Daré Bioscience's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-23.81%
50-Day Moving Average	2.93
200-Day Moving Average	3.26
Relative Strength Index (RSI)	43.94
Average Volume (20 Days)	10,884

Short Selling Information

The latest short interest is 53,655, so 0.61% of the outstanding shares have been sold short.

Short Interest	53,655
Short Previous Month	47,369
Short % of Shares Out	0.61%
Short % of Float	0.62%
Short Ratio (days to cover)	3.11

Income Statement

In the last 12 months, Daré Bioscience had revenue of $25,909 and -$1.68 million in losses. Loss per share was -$0.20.

Revenue	25,909
Gross Profit	-14.27M
Operating Income	-22.01M
Pretax Income	-28.87M
Net Income	-1.68M
EBITDA	-21.82M
EBIT	-22.01M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $10.33 million in cash and $3.57 million in debt, giving a net cash position of $6.76 million or $0.76 per share.

Cash & Cash Equivalents	10.33M
Total Debt	3.57M
Net Cash	6.76M
Net Cash Per Share	$0.76
Equity (Book Value)	-9.56M
Book Value Per Share	-1.08
Working Capital	-9.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $6.74 million and capital expenditures -$723,081, giving a free cash flow of $6.01 million.

Operating Cash Flow	6.74M
Capital Expenditures	-723,081
Free Cash Flow	6.01M
FCF Per Share	$0.68

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-84,951.68%
Pretax Margin	-6,470.92%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	23,210.41%

Dividends & Yields

Daré Bioscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.25%
Shareholder Yield	-13.25%
Earnings Yield	-6.58%
FCF Yield	23.59%

Analyst Forecast

The average price target for Daré Bioscience is $20.33, which is 605.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.33
Price Target Difference	605.90%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	762.28%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 1, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jul 1, 2024
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2